DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 27 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -85.7% | 956 | 0.0% | 0.00% | – |
| Q3 2016 | $14,000 | +55.6% | 956 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +12.5% | 956 | +7.1% | 0.00% | – |
| Q1 2016 | $8,000 | -20.0% | 893 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -23.1% | 893 | 0.0% | 0.00% | – |
| Q3 2015 | $13,000 | +44.4% | 893 | +31.7% | 0.00% | – |
| Q2 2015 | $9,000 | +28.6% | 678 | +24.6% | 0.00% | – |
| Q1 2015 | $7,000 | +16.7% | 544 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | +20.0% | 544 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | 0.0% | 544 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | – | 544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 194,340 | $253,000 | 0.02% |
| MIDDLETON & CO INC/MA | 15,848 | $21,000 | 0.01% |
| Acrospire Investment Management LLC | 4,220 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,942 | $26,000 | 0.00% |
| A.R.T. Advisors, LLC | 32,426 | $42,000 | 0.00% |
| FNY Partners Fund LP | 500 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 43,447 | $56,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 13,200 | $17,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,378 | $32,000 | 0.00% |
| MORGAN STANLEY | 7,566 | $10,000 | 0.00% |